Andrew M. Redmond

Learn More
Multiple factors influence the outcome of fungal infection of the central nervous system (CNS). The host and the pathogen in concert with drug delivery across the blood-brain barrier and drug activity are key factors in outcome. Drug costs can be prohibitively expensive. Drug toxicity with standard antifungal agents such as amphotericin B (infusion rate(More)
Synergy between HIV and malaria is being increasingly recognized. We examined the antimalarial activity of sera from subjects receiving chloroquine, no drugs or HAART. Sera from subjects taking ritonavir-boosted saquinavir or lopinavir significantly inhibited parasite growth (median of 55 and 69% inhibition, respectively). These results indicate that(More)
1440 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 9, September 2007 9. Martiniuk F, Tambini M, Rahimian J, Moreira A, Yee H, Tchou-Wong KM, et al. Identifi cation of novel Hsp65 RFLPs for Mycobacterium leprae. J Drugs Dermatol. 2007;6:268–74. 10. Frommel D, Teykle-Haimonot R, Verdie M, Negesse Y, Bulto T, Denis F. HIV infection and leprosy:(More)
CD103⁺ dermal dendritic cells (dDCs) are a recently described DC subset of the skin shown to be the principal migratory DCs capable of efficiently cross-presenting antigens and activating CD8⁺ T cells. Harnessing their activity would promote vaccine efficacy, but it has been unclear how this can be achieved. We tested a panel of adjuvants for their ability(More)
The World Health Organization’s Global Health Observatory estimates that 78 million people have been infected with the human immunodeficiency virus (HIV) during the course of the epidemic, and that 39 million men, women, and children have died.1 Nearly 1 in 20 adults in sub-Saharan Africa are currently living with the infection. HIV represents one of the(More)
  • 1